Medtronic’s InterStim X System Receives the US FDA’s Approval for the Treatment of Bladder and Bowel Control
Shots:
- The US FDA has approved new recharge-free InterStim X that are used for the treatment of OAB, chronic FI, and non-obstructive urinary retention & enabled the most personalized options to fit patient lifestyles
- The new InterStim X system provides 10 to 15yrs. of battery life without the need to recharge. The device is expected to be available shortly
- Additionally, rechargeable InterStim Micro device offers 15+ yrs. of battery life with regular recharging. Both systems are the first smart programming device that looks like a common smartphone that offers the patients to separately adjust choice of 11 therapy settings at home or outside
Ref: Medtronic | Image: Medtronic
Click here to read the full press release
Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on connect@pharmashots.com
